Marqibo

Generic name:vincristine liposome [ vin-KRIS-teen-LYE-poe-some ]
Drug class:Mitotic inhibitors

Medically reviewed by Philip Thornton, DipPharm. Last updated on Apr 11, 2022.

What is Marqibo?

Marqibo is a cancer medication that interferes with the growth of cancer cells and slows their spread in the body.

Marqibo is used to treat a type of blood cancer called Philadelphia chromosome negative acute lymphoblastic leukemia (ALL). It is usually given after at least two other cancer medications have been tried without success.

Marqibo is given after at least two other cancer treatments did not work or have stopped working.

Warnings

You should not Marqibo if you have Charcot-Marie-Tooth syndrome or other conditions that cause damage to myelin (protective covering of the nerves in your brain and spinal cord).

Before taking this medicine

You should not use Marqibo if you are allergic to vincristine liposome, or if you have Charcot-Marie-Tooth syndrome or other conditions that cause damage to myelin (protective covering of the nerves in your brain and spinal cord).

To make sure Marqibo is safe for you, tell your doctor if you have:

• liver disease;

• a nerve-muscle disorder such as myasthenia gravis, ALS (Lou Gehrig's disease), multiple sclerosis, or muscular dystrophy;

• a bowel obstruction called paralytic ileus; or

• peripheral vascular disease such as Raynaud's syndrome.

Vincristine liposome may harm an unborn baby. Use effective b...